Background Plasmodium vivax infects an estimated 7 million people every year. Previously,
vivax malaria was perceived as a benign condition, particularly when compared to …

The efficient spread of malaria from infected humans to mosquitoes is a major challenge for
malaria elimination initiatives. Gametocytes are the only Plasmodium life stage infectious to …

Coevolution of humans and malaria parasites has generated an intricate balance between
the immune system of the host and virulence factors of the parasite, equilibrating maximal …

Plasmodium vivax is the most widely distributed human malaria parasite. Previous studies
have shown that circulating microparticles during P. vivax acute attacks are indirectly …

Plasmodium vivax infection, the predominant cause of malaria in Asia and Latin America,
affects~ 14 million individuals annually, with considerable adverse effects on wellbeing and …

Abstract Background Malaria transmission in Latin America is generally hypoendemic and
unstable, with Plasmodium vivax as the most prevalent species. However, only a few studies …

Estimation of Plasmodium vivax biomass based on circulating biomarkers indicates the
existence of a predominant biomass outside of the circulation that is not captured by …

Plasmodium vivax, the most widely distributed human malaria parasite, causes severe
clinical syndromes despite low peripheral blood parasitemia. This conundrum is further …

Protein export and host membrane remodeling are crucial for multiple Plasmodium species
to establish a niche in infected hosts. To better understand the contribution of these …

Human malaria caused by Plasmodium vivax infection (vivax malaria) is a major global
health issue. It is the most geographically widespread form of the disease, accounting for 7 …